Skanray Technologies Limited IPO (Skanray Technologies IPO) Detail
Incorporated in 2007, Skanray Technologies is one of the key players in the Indian medical device market. The company is engaged in the designing, development, manufacturing, and marketing of medical devices. The company has a diversified portfolio of products that can be classified into three broad categories -
1.Critical care products,
2.Radiology products,
3.Respiratory management systems.
The company has an in-house R&D team that has been granted 27 patents, 49 trademarks, and 11 design registrations as of December 31, 2020. The company's products are developed in-house and based on company-owned intellectual property. In Fiscal 2020 Skanray Technologies sold its products and services to over 1,830 customers in 20 countries.
As of December 31, 2020, the company has 5 manufacturing facilities, 2 in India, 2 in Italy, and 1 in the Netherland with a combined production capacity of 54,200 units per annum. All five facilities primarily manufacture US FDA and CE certified products. The company also jointly owns a testing facility in Mysore (India) together with the state government and other entities.
Competitive Strengths:
- A Key player in the growing healthcare and medical device market in India.
- Wide portfolio of globally certified portfolio of product
- Strong focus on R&D
- Strong manufacturing capabilities
- Extensive distribution network and good customer relationships
- Experienced leadership team
Company Promoters:
Vishwaprasad Alva, Agnus Capital Llp, Chayadeep Properties Private Limited, and Skanray Healthcare Partners Llp are the company promoters.
Company Financials:
| Particulars | For the year/period ended (₹ in Millions) | ||||
|---|---|---|---|---|---|
| 31-Dec-20 | 31-Mar-20 | 31-Mar-19 | 31-Mar-18 | ||
| Total Assets | 3,485.50 | 2,755.41 | 2,866.01 | 2,675.55 | |
| Total Revenue | 3,505.19 | 1,531.02 | 1,669.22 | 1,419.90 | |
| Profit After Tax | 1,327.30 | 37.61 | (294.19) | (233.23) | |
Objects of the Issue:
- Funding inorganic growth.
- Funding working capital requirements of the company;.
- Investment in subsidiaries.
- Funding capital expenditure requirements of the Company; and
- General corporate purposes
Skanray Technologies IPO Details
| IPO Opening Date | |
| IPO Closing Date | |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | [.] to [.] per equity share |
| Market Lot | |
| Min Order Quantity | |
| Listing At | BSE, NSE |
| Issue Size | |
| Fresh Issue | [.] Eq Shares of ₹10 (aggregating up to ₹400.00 Cr) |
| Offer for Sale | 14,106,347 Eq Shares of ₹10 (aggregating up to ₹[.] Cr) |
0 Comments